Ipsen delivers strong results for the first half of 2019, Consolidated net profit up 11.8%
PARIS–(BUSINESS WIRE)–Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven biopharmaceutical group, today announced financial results for the first…